Inducing secondary metabolite production by the endophytic fungus Chaetomium sp. through fungal-bacterial co-culture and epigenetic modification by Akone, Sergi Herve et al.
Accepted Manuscript
Inducing secondary metabolite production by the endophytic fungus Chaetomium sp.
through fungal-bacterial co-culture and epigenetic modification
Sergi Herve Akone, Attila Mándi, Tibor Kurtán, Rudolf Hartmann, Wenhan Lin,
Georgios Daletos, Peter Proksch
PII: S0040-4020(16)30787-6
DOI: 10.1016/j.tet.2016.08.022
Reference: TET 28003
To appear in: Tetrahedron
Received Date: 5 July 2016
Revised Date: 7 August 2016
Accepted Date: 8 August 2016
Please cite this article as: Akone SH, Mándi A, Kurtán T, Hartmann R, Lin W, Daletos G, Proksch P,
Inducing secondary metabolite production by the endophytic fungus Chaetomium sp. through fungal-
bacterial co-culture and epigenetic modification, Tetrahedron (2016), doi: 10.1016/j.tet.2016.08.022.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Inducing secondary metabolite production by the endophytic fungus Chaetomium sp. 
through fungal-bacterial co-culture and epigenetic modification 
Sergi Herve Akone,a,b Attila Mándi,c Tibor Kurtán,c Rudolf Hartmann,d Wenhan Lin,e 
Georgios Daletos,a*and Peter Prokscha* 
 
aInstitute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine-University, 
Universitaetsstrasse 1, Geb. 26.23, 40225 Duesseldorf, Germany 
bFaculty of Science, Department of Chemistry, University of Douala, P.O. Box. 24157 
Douala, Cameroon. 
cDepartment of Organic Chemistry, University of Debrecen, Egyetem tér 1, P.O. Box. 400, 
4002 Debrecen, Hungary. 
dInstitute of Complex Systems: Strukturbiochemie (ICS-6), Forschungszentrum Julich, 
Wilhelm-Johnen-Strase, 52428 Julich, Germany 
eState Key Laboratory of Natural and Biomimetic Drugs, Peking University, Health Science 
Center, 100191 Beijing, People’s Republic of China. 
 
 
 
 
 
 
 
 
 
 
 
 
* Author to whom correspondence should be addressed;  
E-Mail: georgios.daletos@uni-duesseldorf.de;  
Tel.: +49 211 81 14173; fax: +49 211 81 11923 
E-Mail: proksch@uni-duesseldorf.de;  
Tel.: +49 211 81 14163; fax: +49 211 81 11923 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
ABSTRACT 
Co-culturing the fungal endophyte Chaetomium sp. with the bacterium Bacillus 
subtilis on solid rice medium resulted in an up to 8.3-fold increase in the accumulation of 
constitutively present metabolites that included a 1:1 mixture of 3- and 4-hydroxybenzoic acid 
methyl esters (1 and 2 respectively), and the polyketides acremonisol A (3), SB236050 (4), 
and SB238569 (5). In addition, seven compounds including isosulochrin (6), protocatechuic 
acid methyl ester (7), as well as five new natural products (8-12) were detected in the co-
cultures, but not in axenic fungal cultures. Treatment of Chaetomium sp. with the epigenetic 
modifier suberoylanilide hydroxamic acid or 5-azacytidine resulted in an enhanced 
accumulation of 6, which was likewise detected during co-culture. Compound 5 showed 
strong cytotoxicity against the mouse lymphoma L5178Y cell line with an IC50 value of 1 µM, 
as well as weak antibacterial activity against B. subtilis with an MIC value of 53 µM. 
 
Keywords: Co-cultivation; Chaetomium sp.; Bacillus subtilis; Epigenetic modifiers; natural 
products 
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1. Introduction 
Microorganisms, including soil-dwelling bacteria and fungi, produce a multitude of 
secondary metabolites that play an eminent role in drug discovery, such as the blockbuster 
antibiotic penicillin G produced by Penicillium notatum.1,2 In nature, microorganisms co-exist 
in complex communities, in which they interact with each other.3,4 These interactions are 
mainly based on the production of secondary metabolites that are used as chemical signals for 
communication and/or competition for limited resources, favoring various defense 
mechanisms.5 Therefore, mimicking the natural environment through mixed fermentation of 
different microorganisms (also called co-cultivation or co-culture) may lead to an 
enhancement in the production of compounds. In addition, co-cultivation may trigger the 
expression of silent biosynthetic pathways,6,7 thus resulting in the accumulation of new 
natural products.8,9 During our previous studies, co-cultivation of the endophytic fungus 
Fusarium tricinctum with the bacterium Bacillus subtilis, led to an up to 78-fold enhancement 
in the accumulation of the constitutively present fungal metabolites, along with the induction 
of new secondary metabolites that were not present in both fungal or bacterial axenic 
controls.5 A similar observation was made when co-culturing the soil-dwelling fungus 
Aspergillus terreus with either B. subtilis or with B. cereus.10 Besides the co-cultivation 
approach, treatment of fungi with epigenetic modifiers is another powerful tool for the 
activation of silent genes.11 Recently, the addition of the DNA methyltransferase inhibitor 5-
azacytidine to the endophytic fungus Pestalotiopsis crassiuscula resulted in a change in the 
secondary metabolite pattern and led to the induction of three new cryptic metabolites.12 
During our ongoing search for new fungal secondary metabolites, we isolated the 
endophytic fungus Chaetomium sp. from fresh healthy leaves of Sapium ellipticum collected 
in Cameroon. Species of the genus Chaetomium have been described as endophytes 13 and are 
well known to produce a wide range of natural products such as the anticancer compounds 
chaetocochins A - C, 14 the antibacterial compound furano-polyene 3-epi-aureonitol, 15 and 
the metallo-β-lactamases inhibitors SB236050 and SB238569.16, 17 Given this broad spectrum 
of bioactive secondary metabolites, we investigated a mixed-fermentation of Chaetomium sp. 
with the Gram-positive bacteria B. subtilis and Streptomyces lividans, as well as with 
Mycobacterium tuberculosis. In a further attempt to manipulate the pattern of fungal 
metabolites, Chaetomium sp. was treated with two epigenetic modifiers including the DNA 
methyltransferase inhibitor 5-azacytidine and the histone deacetylase inhibitor, 
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suberoylanilide hydroxamic acid (SAHA). The isolation and structure elucidation of the new 
metabolites (8-12) (Fig. 1), as well as the biological activities of the isolated compounds are 
described.  
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Figure 1. Structures of compounds 1-12.  
 
2. Results and discussion 
Chaetomium sp. was isolated from the Cameroonian medicinal plant Sapium 
ellipticum. When Chaetomium sp. was cultured axenically on solid rice medium, average 
yields per culture flask were 2.8 mg for the known acremonisol A (3),18 13.9 mg for 
SB236050 (4),16,17 132.7 mg for SB238569 (5),16,17 and 14.6 mg for the 1:1 mixture of 3- and 
4-hydroxybenzoic acid methyl esters (1 and 2, respectively)19,20 (Table 1). Co-cultivation of 
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Chaetomium sp. was undertaken with viable or autoclaved cultures of B. subtilis. In both 
cases, a strong accumulation of the 1:1 mixture of 1 and 2 was observed, accounting for a 8.3 
and 7.4-fold increase, respectively, compared to axenic fungal controls (Table 1). However, 
the major polyketides SB236050 (4) and SB238569 (5), which are typical constituents of 
Chaetomium sp., were not detected in co-cultures (Fig. 2). These observations prove that the 
effects of co-cultivation are not uniform for all fungal metabolites, which is in agreement with 
our previously reported data.5,10 In addition, seven compounds, including five new natural 
products (8-12), as well as the known isosulochrin (6) 21 and protocatechuic acid methyl ester 
(7) 22 were only detected in co-cultures of Chaetomium sp. with viable or with autoclaved B. 
subtilis cultures, but were lacking in axenic fungal or bacterial controls (Fig. 2).  
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1
2
3
4
min
4
3
2
1
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Figure 2. HPLC chromatograms of EtOAc extracts from co-culture experiments (detection at UV 235 
nm): (a) B. subtilis control, (b) Chaetomium sp. control, (c) co-culture of Chaetomium sp. with 
autoclaved B. subtilis, (d) co-culture of Chaetomium sp. with viable B. subtilis. 
 
Table 1: Yield of induced metabolites per flask during co-culture of Chaetomium sp. and Bacillus 
subtilis (n=5) vs. axenic controls of Chaetomium sp. (n=5). 
Compound Controla 
(mg) 
Chaetomium sp. 
vs. B. subtilis (mg) 
Increase 
(fold) 
Chaetomium sp. 
vs. autoclaved B. 
subtilis (mg) 
Increase 
(fold) 
1+2 14.58 ± 5.88 121.20 ± 3.60 8.3 108.60 ± 7.20 7.4 
3 2.82 ± 1.26 2.58 ± 0.90 0.9 1.86 ± 0.78 0.7 
a 
5 
7 8 
1+2 
6 
9 10 
11 12 3 
4 
b 
c 
d 
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4 13.92 ± 0.07 n.d.  n.d.  
5 132.72 ± 0.47 n.d.  n.d.  
6  n.d.b n.d.  26.82 ± 3.66  
7 n.d. 3.06 ± 0.08  1.02 ± 1.44  
8 n.d 4.98 ± 0.36  32.40 ± 5.52  
9 n.d. 7.20 ± 0.96  n.d.  
10 n.d. 13.98 ± 0.78  9.06 ± 0.18  
11 n.d. 0.72 ± 0.12  n.d.  
12 n.d. 19.20 ± 1.86  6.72 ± 0.36  
a 
 Chaetomium sp. axenic control.  b  n.d.: not detected 
 
Compound 8 was isolated as a greenish oil. It exhibited a prominent ion peak at m/z 
215.0913 [M+H]+ in the HRESIMS spectrum, corresponding to the molecular formula 
C10H14O5. Inspection of the 1H NMR and COSY spectra of 8 revealed the presence of a 
methoxy group at δH 3.71 (3H, s, 7-OCH3), a methyl group at δH 2.00 (3H, s, H3-2’), as well 
as a continuous spin system composed of two methylene groups at δH 2.37 (2H, m, H2-6) and 
1.95/1.72 (1H, dddd, J = 13.2, 9.8, 8.2, 3.4 Hz, H2a-5; 1H, dddd, J = 13.2, 9.8, 8.2, 6.5 Hz, 
H2b-5), two oxymethine protons at δH 4.80 (1H, ddd, J = 9.0, 6.5, 3.4 Hz, H-4) and 4.27 (1H, 
dt, J =  9.0, 3.0 Hz, H-3), and an olefinic proton at δH 6.72 (1H, dt, J = 3.0, 1.9,  H-2) (Table 
2). In the HMBC spectrum of 8, the correlations observed from 7-OCH3, H-2, and H2-6 to C-7 
(δC 167.4) corroborated the attachment of the methoxy group (7-OCH3) at C-7. Moreover, the 
HMBC correlations from H-4 and H3-2’ to C-1’ (δC 170.8), suggested the presence of an 
acetyl group being located at C-4. These data were similar to those reported for methyl 4-O-
acetyl-4-epi-shikimate,23 the only difference being the absence of the hydroxy group at C-5 in 
8, which is in accordance with the 16 amu molecular weight difference between both 
compounds. The large coupling constant between H-3 and H-4 (J3-4 = 9.0 Hz) indicated their 
trans-diaxial orientation, as reported for methyl 4-O-acetyl-4-epi-shikimate.23 
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Table 2: NMR data of 8 and 11. 
Position            Shikimeran A (8)a                      Quinomeran (11)b 
 δH, mult. (J in Hz)  δC, type δH, mult. (J in Hz) δC, typec 
1  131.8, C   
2 6.72, dt (3.0, 1.9) 139.4, C  153.6, C 
3 4.27, dt (9.0, 3.0) 68.8, CH 8.10, d (8.4) 118.4, CH 
4 4.80, ddd (9.0, 6.5, 
3.4 ) 
74.8, CH 8.53, d (8.4) 138.1, CH 
4a    130.3, C 
5 1.95, dddd (13.2, 
9.8, 8.2, 3.4) 
1.72, dddd (13.2, 
9.8, 8.2, 6.5) 
25.5,CH2 8.08, dd (8.5, 1.5) 128.6,CH 
6 2.37, m 23.5, CH2 7.76, ddd (8.5, 6.9, 
1.5) 
129.5, CH
 
7  167.4, C 7.89, ddd (8.5, 6.9, 
1.5) 
131.0, CH 
8   8.21, dd (8.5, 1.5) 130.9, CH
 
8a    147.7, C 
1’  170.8, C  199.0, C 
2’ 2.00, s 21.2, CH3 3.80, m 42.5, CH2 
3’   4.83, dd (6.9, 5.4) 67.9, CH 
4’    174.5 
4’-
OCH3 
  3.71, s 52.0 
7-
OCH3 
3.71, s 52.1, CH3   
a Measured in (CD3)2CO at 300 (1H) and 75 (13C) MHz. 
b
 Measured in (CD3)2CO at 600 (1H) and 150 (13C) MHz. 
c Data extracted from HSQC and HMBC spectra. 
 
For the determination of the absolute configuration of 8, the solution TDDFT-ECD 
protocol 24 was carried out on the arbitrarily chosen (3R,4R)-8 enantiomer. Merk Molecular 
Force (MMFF) conformational search in CHCl3 resulted in 19 conformers in a 21 kJ/mol 
energy window. These conformers were reoptimized at B3LYP/6-31G(d) in vacuo and 
B97D/TZVP 25, 26 PCM/MeCN levels yielding 4 and 13 low-energy conformers above 2%, 
respectively (Figures S4 and 3, respectively). ECD spectra calculated at various levels 
(B3LYP/TZVP, BH&HLYP/TZVP and PBE0/TZVP in vacuo) for the individual conformers 
optimized in the gas-phase reproduced the ECD pattern of the experimental spectra, while the 
Boltzmann-average spectra did not resemble the experimental ECD. Although all conformers 
had similar computed ECD pattern at most levels, there was considerable wavelength 
deviation among the conformers, which caused the mismatch of the Boltzmann-weighted 
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ECDs. Conformers differed in the orientation of the methoxycarbonyl and the acetoxy groups 
(Figures S4 and S5). 
 
 
Figure 3. Structures and populations of the low-energy B97D/TZVP PCM/MeCN conformers (≥2%) 
of (3R,4R)-8. 
 
In contrast, Boltzmann-weighted ECD spectra of (3R,4R)-8 computed with PCM for 
MeCN at the same three levels for the B97D/TZVP PCM/MeCN reoptimized conformers 
gave nice agreement with the experimental ECD spectrum (Fig. 4) allowing the unambiguous 
determination of the absolute configuration as (3R,4R). 
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Figure 4. Experimental ECD spectrum of 8 in MeCN compared with the Boltzmann-weighted 
B3LYP/TZVP PCM/MeCN ECD spectrum of (3R,4R)-8 computed for the B97D/TZVP PCM/MeCN 
conformers. Bars represent the rotational strength of the lowest-energy conformer. 
 
Moreover, to exclude the possibility of 8 being an artefact formed during extraction 
with EtOAc, shikimic acid was incubated for 72h in EtOAc or MeOH at room temperature; 
however, no formation of the acetylated or methylated derivative, respectively, was observed 
by HPLC and LC-MS analysis. Thus, 8 was identified as a new natural product for which we 
propose the trivial name shikimeran A. 
Compound 9 was isolated as a colorless oil. Its molecular formula was established as 
C16H14O6 based on the prominent ion peak observed at m/z 303.0863 [M+H]+ in the 
HRESIMS spectrum. Inspection of the 1H and 13C NMR spectra revealed only one set of five 
proton and eight carbon resonances, respectively (Table 3), indicating that 9 is a symmetrical 
dimer consisting of two identical monomers. Accordingly, the 1H NMR spectrum (Table 3) of 
9 displayed signals corresponding to six aromatic protons at δH 7.35 (2H, dd, J = 2.0, 1.1 Hz, 
H-6/6’) and 7.02 (4H, H-3/3’ and H-4/4’), two methoxy groups at δH 3.54 (6H, s, 7/7’-OMe), 
and two hydroxy protons at δH 8.65 (2H, br s, 5/5’-OH). In the HMBC spectrum of 2, the 
correlations from H-4 (/4’) to C-2 (/2’) (δC 134.9)  and C-6 (/6’) (δC 116.9), from H-3 (/3’) to 
C-5 (/5’) (δC 157.0) and C-1 (/1’) (δC 132.4), as well as from H-6 (/6’) to C-4 (/4’) (δC 119.1) 
and C-2 (/2’) revealed the presence of a 1,2,4-trisubstituted phenyl ring (ABX spin system). In 
addition, the correlations from 5 (/5’)-OH to C-4 (/4’), C-5 (/5’), and C-6 (/6’) suggested the 
hydroxyl group being located at C-5 (/5’), adjacent to the aromatic protons H-4 (/4’) and H-6 
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(/6’). This assignment was further corroborated by the ROESY correlations between 5 (/5’)-
OH and both H-4 (/4’) and H-6 (/6’). Similarly, the HMBC correlations from 7/ (7’)-OMe and 
H-6 (/6’) to C-7 (/7’) (δC 168.1) suggested that C-1 (/1’) was substituted by a carbomethoxy 
group. The linkage between the two monomers was found to reside between C-2 and C-2’, as 
H-3 (/3’) displayed a strong HMBC correlation to C-2’ (/2), allowing us to assign the planar 
structure of 9. Notably, 9 was previously described as an intermediate in the total synthesis of 
aromatic polyesters containing multiple n-alkyl side chains.27 However, to the best of our 
knowledge, this is the first report of the isolation of 9 from nature. Thus, 9 was identified as a 
new natural product for which the name bipherin A is proposed.  
 
Table 3: NMR data of 9 measured in (CD3)2CO at 300 (1H) and 75 (13C) MHz. 
Position                Bipherin A (9) 
 δH, mult. (J in Hz) δC, type 
1/1’              132.4, C 
2/2’              134.9, C 
3/3’ 7.02a             133.0, CH 
4/4’ 7.02a              119.1, CH 
5/5’              157.0, C 
6/6’ 7.35, dd 
(2.0, 1.1) 
            116.9, CH 
7/7’              168.1, C 
7/7’-OCH3 3.54, s             51.9, CH3 
5/5’-OH 8.65, br s  
a
 Signal overlap prevents determination of couplings. 
 
 
Compound 10 was isolated as a yellowish oil. The HRESIMS spectrum exhibited a 
prominent ion peak at m/z 223.0602 [M+H]+, indicating the molecular formula C11H10O5. The 
1H NMR spectrum of 10 revealed the presence of four coupled signals at δH 7.77 (1H, dt, J = 
8.0, 1.4 Hz, H-6), 7.61 (1H, dd, J = 2.5, 1.4 Hz, H-2), 7.47 (1H, t, J = 8.0 Hz, H-5), and 7.27 
(1H, ddd, J = 8.0, 2.5, 1.4 Hz, H-4) (Table 4), indicating a 1,3-disubstituted benzene system. 
The remaining signals included those of a methoxy group at δH 3.90 (3H, s, 7-OCH3) and two 
geminal olefinic protons at δH 5.83 (1H, d, J = 1.9 Hz, Ha-3’) and 5.09 (1H, d, J = 1.9 Hz, Hb-
3’), representing typical signals of a disubstituted vinyl group. The HMBC correlations from 
H-2, H-6, and 7-OCH3 to C-7 (δC 167.8) suggested the presence of a methyl ester group at C-
1. Moreover, the HMBC correlations from H2-3’ to C-1’ (δC 165.7) and C-2’ (δC 152.1), as 
well as the deshielded signal of the C-3 (157.8) were indicative of a monosubstituted acrylic 
acid moiety, which was connected to C-3 of the benzene ring through an ether bond. Thus, 10 
was identified as a new natural product for which the name chorismeron is proposed. 
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Table 4: NMR data of 10 measured in CD3OD at 500 (1H) and 125 (13C) MHz. 
Position                Chorismeron (10) 
δH, mult. (J in Hz)                 δC, type 
1  133.1, C  
2 7.61, dd (2.5, 1.4) 119.9, CH 
3  157.8, C  
4 7.27, ddd (8.0, 2.5, 1.4) 124.4, CH 
5 7.47, t (8.0) 131.1, CH 
6 7.77, dt (8.0, 1.4) 125.7, CH 
7  167.8, C 
1’  165.7, C 
2’  152.1, C 
3’ 5.09, d (1.9) 
5.83, d (1.9) 
107.2, CH2 
7-OCH3 3.90, s 53.0, CH3 
 
Compound 11 was isolated as a brown oil. The HRESIMS spectrum exhibited a 
prominent ion peak at m/z 260.0915 [M+H]+ consistent with the molecular formula 
C14H13NO4. The 1H NMR spectrum of 11 displayed two separate aromatic spin systems; the 
first consisted of the signals at δH 8.21 (1H, dd, J = 8.5, 1.5 Hz, H-8), 8.08 (1H, dd, J = 8.5, 
1.5 Hz, H-5), 7.89 (1H, ddd, J = 8.5, 6.9, 1.5 Hz, H-7), and 7.76 (1H, ddd, J = 8.5, 6.9, 1.5 
Hz, H-6), typical of a disubstituted aromatic ring (ABCD spin system) (Table 2). The second 
spin system consisted of two ortho protons at δH 8.53 (1H, d, J = 8.4 Hz, H-4) and 8.10 (1H, 
d, J = 8.4 Hz, H-3) (Table 2). These signals were indicative of a quinoline moiety, as 
confirmed by the HMBC correlations from H-5 to C-7 (δC 131.0), C-8a (δC 147.7), and C-4 
(δC 138.1), from H-8 to C-6 (δC 129.5) and C-4a (δC 130.3), and from H-4 to C-5 (δC 128.6), C-
8a, and C-2 (δC 153.6) (Fig. 5). The remaining signals of a methylene group resonating at δH 
3.80 (2H, m, H2-2’), an oxymethine proton at δH 4.83 (1H, dd, J = 6.9, 5.4 Hz, H-3’) and a 
methoxy signal at δH 3.71 (3H, s, 4’-OCH3) were attributed to a 2-hydroxy-4-oxobutanoic 
acid methyl ester moiety, as supported by the COSY correlations between H2-2’ and H-3’, as 
well as by the HMBC correlations from 4’-OCH3 to C-3’(δC 67.9) and C-4’ (δC 174.5), and 
from both H2-2’ and H-3’to C-1’ (δC 199.0) and C-4’ (Fig. 5). Finally, the HMBC correlation 
from H-3 to C-1’ corroborated the attachment of the 2-hydroxy-4-oxobutanoic acid methyl 
ester moiety at C-2 of the quinoline ring. The baseline ECD spectrum of 11 in acetonitrile 
indicated that it is a racemic mixture (Figure S20). Thus, 11 was identified as a new natural 
product for which the name quinomeran is proposed. 
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Figure 5. COSY (bold), key ROESY (dashed), and HMBC (plain) correlations of 11 and 12 
Compound 12 was isolated as a yellow amorphous powder. The molecular formula of 
12 was determined as C16H12O6 based on the prominent ion peak at m/z 301.0706 [M+H]+. It 
exhibited UV absorption maxima at 202, 236, and 361 nm, typical for dibenzo-α-pyrone 
derivatives. Inspection of the 1H NMR (Table 5) of 12 indicated the presence of two meta-
coupled protons at δH 8.27 (1H, d, J = 1.9 Hz, H-5) and 7.55 (1H, d, J = 1.9 Hz, H-7), as well 
as an ABX-type spin system, consisting of three aromatic protons at δH 8.28 (1H, d, J = 8.8 
Hz, H-1’), δH 7.37 (1H, dd, J = 8.8, 2.7 Hz, H-2’), and δH 7.56 (1H, d, J = 2.7 Hz, H-4’). 
Additional signals included those of two methoxy groups at δH 3.96 (3H, s, 8-OCH3) and 3.90 
(3H, s, 9-OCH3), and a phenolic hydroxy proton at δH 10.55 (1H, s, 3’-OH). Further detailed 
analysis of the 2D NMR (COSY, HSQC, and HMBC) spectra allowed us to establish the 
substitution pattern of the dibenzo-α-pyrone skeleton of 12, as shown in Figure 1. 
Accordingly, the position of the hydroxy group (3’-OH) was assigned at C-3’, as it showed 
ROESY correlations to H-2’ and H-4’ (Fig. 5). Moreover, the HMBC correlations from 9-
OCH3, H-7, and H-5 to C-9 (δC 165.6) corroborated the presence of a carbomethoxy group 
and its attachment at C-6. Finally, the remaining methoxy group (8-OCH3) was assigned at C-
8 (δC 147.3), as supported by the respective HMBC correlation, as well as by its ROESY 
correlation with H-7 (Figure 2). Thus, 12 was identified as a new natural product for which 
the name serkydayn is proposed. 
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Table 5: NMR data of 12 measured in DMSO-d6 at 300 (1H) and 75 (13C) MHz. 
Position Serkydayn (12)  
 δH, mult. (J in Hz) δC, type 
1   
2  159.4, C 
3  118.7, C 
4  125.1, C 
4a  121.9, C 
5 8.27, d (1.9) 115.5, CH 
6  125.7, C 
7 7.55, d (1.9) 110.8, CH 
8  147.3, C
 
8a  142.1, C 
1’ 8.28, d (8.8) 125.1, CH 
2’ 7.37, dd (8.8, 2.7) 124.1, CH 
3’  158.8, C 
4’ 7.56, d (2.7) 113.8, CH 
9  165.6, C 
9-OMe 3.90, s 52.4, CH3 
8-OMe 3.96, s 56.1, CH3 
3’-OH 10.55, s  
 
The new metabolites 8, 9, 10, and 12 probably originate from Chaetomium sp. based 
on structural analogies with the known metabolites (1-7), which were obtained from the 
axenic fungal control. Compound, 11 is the only quinoline derivative in this series of 
metabolites, which highlights the value of the co-cultivation approach as a powerful tool to 
activate silent biosynthetic gene clusters in microorganisms. Quinolines produced by fungi 
have already been reported,28,29 and thus the fungal origin of 11 is likely. Interestingly, 
compounds 8, 10 and 12 were detected during co-cultivation of Chaetomium sp. with viable 
or autoclaved cultures of B. subtilis, whereas compounds 9 and 11 were only detected during 
co-cultivation of Chaetomium sp. with viable B. subtilis cultures. These data indicate that the 
effect of heat sterilized bacterial biomass is not uniform for all fungal metabolites. 
It is worth mentioning that the production of fungal metabolites in the co-cultures was 
found to correlate with the time of preincubation of the solid rice medium with B. subtilis 
prior to inoculation with Chaetomium sp.. The strongest effect was observed when the fungus 
was added 4 days after the rice medium had been inoculated with viable B. subtilis (data not 
shown). During co-cultivation, the fungal growth was slowed down compared to axenic 
controls of Chaetomium sp., but recovered after seven to nine days of co-culture. These data 
demonstrate an inhibitory effect due to the presence of the bacterium, which is in agreement 
with our previously reported results.5 
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In a second set of experiments, the endophytic bacterium Streptomyces lividans30 was 
chosen for co-cultivation with Chaetomium sp.. However, no induction of fungal metabolites 
was detected. Likewise, no induction of fungal metabolites was observed when Chaetomium 
sp. was co-cultured with autoclaved Mycobacterium smegmatis (data not shown). These 
results suggest that the fungal response is specific toward different prokaryotes, as previously 
also described for other fungi.5,10  
Taking into consideration that posttranslational modifications of histones influence the 
pattern of secondary metabolites in filamentous fungi,31 Chaetomium sp. was cultured on 
solid rice medium in the presence of the DNA methyltransferase inhibitor 5-azacytidine or the 
histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA). The HPLC 
chromatographic profiles of the respective extracts were significantly different in comparison 
to those of the axenic fungal controls, but were very similar to each other and showed the 
induction of two new peaks, which were not present in the fungal controls (Figure S25). 
Interestingly, one of the induced peaks was identified as the known isosulochrin (6), which 
was also detected during co-cultivation of Chaetomium sp. with B. subtilis. Thus, the effect on 
the accumulation of fungal metabolites during co-cultivation may be partially triggered by 
histone modifications due to microbial crosstalk. 
All compounds isolated in this study were assayed in vitro for their antibacterial 
activities against the Gram-positive bacteria Staphylococcus aureus ATCC 25923, 
Enterococcus faecalis ATCC 29212, and Bacillus subtilis 168 trpC2; the latter being the 
bacterial strain used for co-cultivation. The compounds were likewise assayed against the 
Gram-negative bacterium Acinetobacter baumannii, as well as against Mycobacterium 
tuberculosis. Compound 12 exhibited weak to moderate activity against B. subtilis with an 
MIC value of 53 µM, whereas the remaining compounds exhibited no activity (MIC > 100 
µM). In addition, all compounds were evaluated for their effects on the growth of the mouse 
lymphoma L5178Y cell line. Compound 12 likewise showed the strongest activity with an 
IC50 value of 1 µM. Compounds 11 and 7 displayed only weak cytoxicity with IC50 values of 
38.6 and 20.8 µM, respectively. Interestingly, the biosynthesis of 12 was induced only during 
fungal/bacterial co-cultivation, and thus it could be assumed that Chaetomium sp. initiated its 
production as a stress response to suppress its competitor. 
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3. Conclusion 
In conclusion, the axenic culture of Chaetomium sp. grown on solid rice medium 
yielded five known metabolites (1 ─ 5). When Chaetomium sp. was grown in mixed 
cultures with viable or autoclaved cultures of B. subtilis, a strong accumulation of the 1:1 
mixture of 1 and 2 was observed compared to axenic fungal or bacterial controls. In 
addition, five new natural products (8 ─ 12) together with 6 and 7 were only detected in 
the co-cultures. Likewise, induction of 6 was observed when Chaetomium sp. was 
cultured on solid rice medium with the epigenetic modifiers 5-azacytidine or SAHA. 
Thus, our results highlight the potential of the co-cultivation and epigenetic modification 
as powerful strategies for triggering the production of cryptic fungal secondary 
metabolites. 
 
4. Experimental Section 
4.1. General Experimental Procedures 
 Optical rotations were determined on a Perkin-Elmer-241 MC polarimeter. 1H, 13C and 
2D NMR spectra were recorded in deuterated solvents on a Bruker ARX 300, Avance III 500, 
Avance DMX 600 or AV III HD 700 NMR spectrometers. Mass spectra were obtained on a 
LC-MS HP1100 Agilent Finnigan LCQ Deca XP Thermoquest and high-resolution mass  
(HRESIMS) spectra were measured on a FTHRMS-Orbitrap (Thermo-Finnigan) mass 
spectrometer. Solvents were distilled prior to use, and spectral grade solvents were used for 
spectroscopic measurements. HPLC analysis was performed with a Dionex UltiMate3400 SD 
with a LPG-3400SD Pump coupled to a photodiode array detector (DAD3000RS); routine 
detection was at 235, 254, 280, and 340 nm. The separation column (125 mm × 4 mm) was 
prefilled with Eurosphere-10 C18 (Knauer, Germany), and the following gradient was used 
(MeOH, 0.1 % HCOOH
 
 in H2O): 0 min (10 % MeOH), 5 min (10% MeOH), 35 min (100 % 
MeOH), 45 min (100 % MeOH). Semi-preparative HPLC was performed using a Merck 
Hitachi HPLC System (UV detector L-7400; Pump L-7100; Eurosphere-100 C18, 300 mm × 
8 mm, Knauer, Germany). Column chromatography included LH-20 Sephadex and Merck 
MN Silica gel 60 M (0.04-0.063 mm). TLC plates with silica gel F254 (Merck, Darmstadt, 
Germany) were used to monitor fractions (CH2Cl2/MeOH mixtures as mobile phase); 
detection was under UV at 254 and 366 nm or by spraying the plates with anisaldehyde 
reagent. Bacterial growth was monitored by measuring OD600 in a Tecan microtiter plate 
reader (Infinite M200, Tecan). 
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4.2. Biological material 
 Chaetomium sp. was isolated from fresh healthy leaves of Sapium ellipticum 
(Euphorbiaceae) collected in the west region of Cameroon in January 2015. The fungus was 
isolated under sterile conditions from the inner tissue of the leaf according to the procedure 
described by Kjer et al.32 The identification was performed following a molecular biological 
protocol by DNA amplification and sequencing of the ITS region. The sequence data have 
been submitted to GenBank, accession number KU051539. The bacterial strain panel used on 
this study included the standard laboratory strains, B. subtilis 168 trpC2,33 S. lividans TK24,34 
and M. smegamatis (mc2 155).35 
 
4.3. Co-cultivation experiment of Chaetomium sp. with B. subtilis 168 trpC2 
The fungal and bacterial strains were cultivated in Erlenmeyer flask (1 L) containing 
solid rice media for isolation and characterization of secondary metabolites. Twenty-five 
Erlenmeyer flasks (five flasks for axenic Chaetomium sp., five for co-cultures of Chaetomium 
sp. and B. subtilis, five for Chaetomium sp. treated with autoclaved B. subtilis, five for axenic 
B. subtilis and five for autoclaved B. subtilis) containing 60.0 mL of distilled water and 50.0 g 
of commercially available milk rice (Milch-Reis, ORYZA) each were autoclaved before the 
fungus and the bacterium were inoculated. 
The bacterium B. subtilis was grown in lysogeny broth (LB). An overnight culture of 
this bacterium was used to inoculate prewarmed LB medium (1:20), which was afterwards 
incubated at 37°C with shaking at 200 rpm to mid exponential growth phase (optical density 
at 600 nm (OD600) of 0.2-0.4). A 10 mL volume of the bacterial culture was then added to the 
rice medium, which was further incubated for 4 days at 37°C. 
This preincubation was followed by the addition of Chaetomium sp. grown on malt 
agar (three pieces, 1 cm-1 cm) to the rice medium containing viable B. subtilis. On the other 
hand, after 4 days incubation, ten flasks cultured with B. subtilis were autoclaved followed by 
addition of the fungus to five of them, in the same manner like for viable cultures of B. 
subtilis. Both microorganisms were also grown axenically on rice medium. Co-cultures and 
axenic cultures of Chaetomium sp. and B. subtilis were kept under static conditions at 23°C 
until they reached their stationary phase of growth (3 weeks for Chaetomium sp. and B. 
subtilis; 5 weeks for co-cultures). For extraction, 300 mL of EtOAc was added to the cultures, 
and then the resulting mixture was shaken at 140 rpm for 9 h. The cultures were further left 
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overnight and filtered on the following day using a Buchner funnel. The resulting extract was 
washed with demineralised water and then evaporated under vacuum to remove EtOAc. Each 
extract was then dissolved in 60 mL of MeOH, and then 15 µL of this was injected into the 
analytical HPLC column. 
 
4.4. Co-cultivation experiment of Chaetomium sp. with S. lividans TK24 
The co-cultivation of Chaetomium sp. with S. lividans was done in the same manner as 
with viable B. subtilis. Fifteen Erlenmeyer flasks (five for axenic Chaetomium sp., five for 
Chaetomium sp. and S. lividans and five for axenic S. lividans) containing 60.0 mL of Yeast 
Malt (YM) medium and 50.0 g of commercially available milk rice (Milch-Reis, ORYZA) 
each were autoclaved before inoculating the fungus and the bacterium. An overnight culture 
of Streptomyces lividans was used to inoculate prewarmed YM medium (1:20), which was 
then incubated at 30°C with shaking at 200 rpm to mid exponential growth phase. The 
corresponding preculture was afterwards incubated in fresh YM medium overnight to reach 
exponential growth phase. Then 10 mL volume of the bacterial culture was added to the rice 
medium, which was further incubated for four days at 30°C. After this preincubation, we 
proceeded in the same manner as described in the co-cultivation experiment of Chaetomium 
sp. and B. subtilis 168 trpC2. 
 
4.5. Co-cultivation experiment of Chaetomium sp. with Mycobacterium smegmatis 
(mc2 155) 
The fungal and the bacterial strains were cultivated in Erlenmeyer flask (1L) 
containing solid rice media for isolation and characterization of secondary metabolites. 
Erlenmeyer flasks containing 60.0 mL of distilled water and 50.0 g of commercially available 
milk rice (Milch-Reis, ORYZA) each were autoclaved before the fungus and the bacterium 
were inoculated. M. smegmatis was grown in Middelbrook 7H9 media supplemented with 
0.5% (v/v) glycerol, 0.05% (v/v) tyloxapol and 10% (v/v) ADS enrichment (5%, w/v, bovine 
serum albumin fraction V; 2%, w/v, glucose; 0.85%, w/v, sodium chloride) until exponential 
growth phase (OD 600 nm of 0.5-0.8). 10 mL volume of the bacterial culture was then added 
to the rice medium, which was further incubated for 4 days 37°C and finally autoclaved. After 
this preincubation, we proceeded in the same manner as described in the co-cultivation 
experiment of Chaetomium sp. and B. subtilis 168 trpC2. 
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4.6. Treatment with epigenetic modifiers 
The treatment of Chaetomium sp. with the histone deacetylase inhibitor SAHA or with 
DNA methyltranferase inhibitor 5-azacytidine, was carried out to compare the production of 
cryptic fungal metabolites induced during the co-culture experiments with fungal cultures 
being treated with epigenetic modifications. Ten flasks (two flasks for axenic Chaetomium 
sp., two flasks for Chaetomium sp. and SAHA, two flasks for Chaetomium sp. and 5-
azacytidine, two flask of SAHA and two flask of 5-azacytidine) containing 60.0 mL of 
distilled water and 50.0 g of commercially available milk rice (Milch-Reis, ORYZA) each 
were autoclaved before inoculation of the fungus and addition of the epigenetic modifiers. 
Three pieces of Chaetomium sp. grown on malt agar were added to the autoclaved rice 
medium under sterile conditions and incubated for two days. This preincubation was followed 
by the addition of 10 mL of the solution (Sterilized Water-EtOH 21:4) of each epigenetic 
modifier (6 mM each) under sterile conditions. Epigenetic and axenic cultures of Chaetomium 
sp. were kept under static conditions at 23°C until they reached their stationary phase of 
growth (3 weeks for Chaetomium sp.; 4 weeks for epigenetic cultures). After this incubation, 
we proceeded in the same manner as described in the co-cultivation experiments of 
Chaetomium sp. and B. subtilis 168 trpC2. 
 
4.7. Extraction and isolation 
The crude extract obtained from co-cultures of Chaetomium sp. with B. subtilis (6.0 g) 
was subjected to vacuum liquid chromatography (VLC) on silica gel employing a step 
gradient of n-hexane-EtOAc then CH2Cl2-MeOH to give seven fractions A-G. Fraction B, 
eluted with n-hexane/EtOAc (6:4) was subjected to repeated VLC, using only a step gradient 
of n-hexane-EtOAc to yield nine subfractions B1-B9. Subfraction B2, eluted with n-hexane-
EtOAc (9:1, v/v), was further purified using Sephadex LH-20 followed by semipreparative 
HPLC with MeOH-H2O (0.1%TFA) to afford the mixture 1 and 2 (50 mg). Subfraction B3, 
eluted with n-hexane-EtOAc (8.5:1.5, v/v), was purified by semipreparative HPLC with 
MeOH-H2O (0.1%TFA) to yield 11 (1.1 mg) and 7 (1.2 mg). Subfraction B4, eluted with n-
hexane-EtOAc (8:2, v/v), was further purified using Sephadex LH-20 followed by 
semipreparative HPLC with MeOH-H2O to yield 8 (11 mg), 12 (6 mg) and 6 (4 mg). 
Subfraction B5, eluted with n-hexane-EtOAc (7.5:2.5, v/v), was treated in the same manner as 
B4 to afford 9 (8 mg), 10 (2 mg) and 3 (3.8 mg).  
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The crude extract of the axenic culture of Chaetomium sp. (1.6 g) was also subjected 
to VLC on silica gel employing a step gradient of n-hexane-EtOAc followed by CH2Cl2-
MeOH to give six fractions A-F. Fraction E, eluted with EtOAc, was purified by 
semipreparative HPLC (MeOH-H2O) to yield 4 (1.9 mg) and 5 (3.1 mg). Compounds 1, 2, 3, 
4, 5, 6, and 7 were identified by comparing their 1H NMR, LC-MS and UV data with those 
published.16,18-22 
The crude extracts resulting from co-cultivation of Chaetomium sp. with S. lividans or 
with M. smegmatis as well as those from the epigenetic modifier experiments were directly 
submitted to analytical HPLC and no further work up was undertaken due to their limited 
amounts. 
 
4.7.1. Shikimeran A (8). Greenish oil; [α]20D -58 (c 1.01, MeOH); UV (MeOH) λmax: 227 
nm; ECD (MeCN,λ [nm] (∆ɛ), c = 3.50x10-4M): 250 (0.20), 220 (-1.72), 192 (1.29); 1H and 
13C NMR see Table 2; HRESIMS [M+H]+ m/z 215.0913 (calcd for C10H15O5, 215.0914). 
 
4.7.2. Bipherin A (9). Colorless oil; UV (MeOH) λmax: 233 and 307 nm; 1H and 13C NMR see 
Table 3; HRESIMS [M+H]+ m/z 303.0863 (calcd for C16H15O6, 303.0863). 
 
4.7.3. Chorismeron (10). Yellowish oil; UV (MeOH) λmax: 205 and 289 nm; 1H and 13C NMR 
see Table 4; HRESIMS [M+H]+ m/z 223.0602 (calcd for C11H11O5, 223.0601).  
 
4.7.4. Quinomeran (11). Brown oil; [α]20D 0 (c 0.3, MeOH); UV (MeOH) λmax: 208, 246, and 
297 nm; 1H and 13C NMR see Table 2; HRESIMS [M+H]+ m/z 260.0915 (calcd for 
C14H14NO4, 260.0917). 
 
4.7.5. Serkydayn (12). Yellow amorphous powder; UV (MeOH) λmax: 202, 236, and 361 nm; 
1H and 13C NMR see Table 5; HRESIMS [M+H]+ m/z 301.0706 (calcd for 
C16H13O6, 301.0707). 
 
4.8. Computational section 
 Mixed torsional/low-frequency mode conformational searches were carried out by 
means of the Macromodel 9.9.223 software using the Merck Molecular Force Field (MMFF) 
with an implicit solvent model for CHCl3.36 Geometry reoptimizations were carried out at the 
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B3LYP/6-31G(d) level in vacuo and the B97D/TZVP level 25, 26 with the PCM solvent model 
for MeCN. TDDFT ECD calculations were run with various functional (B3LYP, BH&HLYP, 
PBE0) and the TZVP basis set as implemented in the Gaussian 09 package with the same or 
no solvent model as in the preceding DFT optimization step.37 ECD spectra were generated as 
sums of Gaussians with 3000 cm-1 widths at half-height (corresponding to ca. 15 nm at 220 
nm), using dipolevelocity-computed rotational strength values.38 Boltzmann distributions 
were estimated from the ZPVE-corrected B3LYP/6-31G(d) energies in the gas-phase 
calculations and from the B97D/TZVP energies in the solvated ones. The MOLEKEL 
software package was used for visualization of the results.39 
 
4.9. Antibacterial assay 
Measurement of MIC values were done by the broth microdilution method according 
to CLSI guidelines.40 The direct colony suspension method was used with an inoculum of 5 x 
105 colony forming units/mL after the last dilution step for inoculum preparation. Compounds 
were added from stock solution (10 mg/mL in DMSO), resulting in a final DMSO amount of 
0.64% at the highest antibiotics concentration tested (64 µg/mL). Serial 2-fold dilutions of 
antibiotics were prepared with DMSO being diluted along with the compounds. 
 
4.10. Antituberculosis assay 
The resazurin dye reduction method was performed as a metabolic assay to evaluate 
the growth inhibition of M. tuberculosis. M. tuberculosis cells were grown aerobically at 37°C 
in Middlebrook 7H9 media supplemented with 0.5% (v/v) glycerol, 0.05% (v/v) Tyloxapol, 
and 10% (v/v) ADS enrichment (5%,w/v, bovine serum albumin fraction V; 2%, w/v, 
glucose; 0.85%, w/v, sodium chloride). Bacteria were precultured until log-phase (OD 600 
nm~1) and then seeded at 1 x 105 cells per well in a total volume of 100 µL in 96-well round-
bottom microtiter plates and incubated with test substances for 6 days. For viability 
determination, 10 µL of resazurin solution (100 µg/mL, Sima-Alderich) was added per well 
and incubated for ca. 8h. Then cells were fixed at room temperature for 30 mn after addition 
of formalin (5%, v/v, final concentration), and fluorescence was measured using a microplate 
reader (excitation 540 nm, emission 590 nm). Residual growth was calculated relative to 
rifampicin-treated (0% growth) and DMSO treated (100% growth) controls. 
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4.11. Cell viability assay 
Cytotoxicity was tested against L5178Y mouse lymphoma cells using an MTT (=3-(4, 
5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) assay and compared to that of 
untreated controls, as described previously.41  Experiments were repeated three times and 
carried out in triplicate. As negative controls, media with 0.1% EGMME/ DMSO were 
included in the experiments. The depsipeptide kahalalide F, isolated from Elysia grandifolia 
was used as a positive control.  
 
Aknowledgements 
The financial support of the Manchot Foundation granted to P.P. is gratefully 
acknowledged. S.H.A. wants to thank DAAD (Deutscher Akademischer Austauschdienst; 
German Academic Exchange Service) for a doctoral scholarship. T.K. and A.M. thank the 
Hungarian National research Foundation (OTKA K105871) for financial support and the 
National Information infrastructure Development Institute (NIIFI 10038) for CPU time. We 
are indebted to Professor W.E.G. Müller (Johannes Gutemberg University, Mainz, Germany), 
for cytotoxicity assays. We also thank Professor R. Kalscheuer (Heinrich-Heine University 
Duesseldorf) for antibacterial assays. 
 
References 
1. Brakhage, A.A. Microbiol. Mol. Biol. R. 1998, 62, 547-585. 
2. Brakhage, A.A.; V. Schroeckh. Fungal. Genet. Biol. 2011, 48, 15-22. 
3. Strobel, G.; B. Daisy. Microbiol. Mol. Biol. R. 2003, 67, 491-502. 
4. Aly, A.H.; A. Debbab; Proksch, P. Appl Microbiol Biotechnol. 2011, 90, 1829-1845. 
5. Ola, A.R.B.; Thomy, D.; Lai, D.; Brötz-Oesterhelt, H.; Proksch, P. J. Nat. Prod. 2013, 
76, 2094-2099. 
6. Rateb, M.E.; Hallyburton, I.; Houssen, W.E.; Bull, A.T.; Goodfellow, M.; Santhanam, 
R.;  Jaspars, M.; Rateb, R.E. RSC Adv. 2013, 3, 14444-14450. 
7. Zuck, K.M.; Shipley, S.; Newman, D.J. J. Nat. Prod. 2011, 74, 1653-1657. 
8. Schroeckh, V.; K.; Nützmann, H.-W.; Shelest, E.; Schmidt-Heck, W.; Schuemann, J.; 
Martin, K.; Hertweck, C.; Brakhage, A.A. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 
14558-14563. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
22 
 
9. Oh, D.-C;  Kauffman, C. A.; , Jensen, P. R. ; Fenical, W. J. Nat. Prod. 2007, 70, 515- 
520. 
10 Chen, H.; Aktas, N.; Konuklugil, B.; Mandi, A.; Daletos, G.; Lin, W.; Proksch, P. 
Tetrahedron Lett. 2015, 56, 5317-5320. 
11. Scherlach, K.; C. Hertweck, Org. Biomol. Chem. 2009. 7, 1753-1760. 
12. Yang, X. L.; Huang, L.; Ruan, X. L. J. Asian. Nat. Prod. Res. 2014, 16, 412-417.  
13. Kabbaj, F. Z.; Lu, S.; Faouzi, M. E. A.; Meddah, B.; Proksch, P.; Cherrah, Y.; 
Altenbach, H.J.; Aly A.H.; Chadli, A.; Debbab, A. Bioorg. Med. Chem. 2015, 23, 126-
131.  
14. Li, G.-Y.; Li, B.-G.; Yang, T.; Yan, J.-F.; Liu, G.-Y.; Zhang, G.-L. J. Nat. Prod. 2006, 
69, 1374-1376. 
15. Marwah, R. G.; Fatope, M. O.; Deadman, M. L.; Al-Maqbali, Y. M.; Husband, J. 
Tetrahedron 2007, 63, 8174-8180.  
16. Payne, D. J.; Hueso-Rodríguez, J. A.; Boyd, H.; Concha, N. O.; Janson, C. A.; Gilpin, 
M.; Bateson, J.H.; Cheever, C.; Niconovich, N.L.; Pearson, S.; Rittenhouse, S.; Tew, 
D.; Díez, E.; Pérez, P.; De La Fuente, J.; Rees, M.; Rivera-Sagredo, A. Antimicrob. 
Agents. Chemother. 2002, 46, 1880-1886. 
17. Lösgen, S; Schlörke, O.; Meindl, K.; Herbst‐Irmer, R.; Zeeck, A.  Eur. J. Org. Chem. 
2007, 21, 2191-2196. 
18. Pontius, A.; Mohamed, I.; Krick, A.; Kehraus, S.; König, G. M. J. Nat. Prod. 2008, 
71, 272-274.  
19. Chi-Hwan, L. J. Agric. Sci. 2002, 29, 91-97. 
20. Cao, L.-L.; Tian, H.-Y; Wang, Y.-S; Zhou, X.-F; Jiang, R.-W; Liu, Y.-H. J. Trop. 
Oceanogr. 2015, 34, 77-82. 
21.        Shimada, A.; Takahashi, I.; Kawano, T.; Kimurab, Y. Z. Naturforsch. B.    
             2001, 56, 797-803. 
22.       Miyazawa, M.; Oshima, T.; Koshio, K.; Itsuzaki, Y.; Anzai, J.  J. Agric. Food  
          Chem 2003, 51,  6953-6956. 
23. Armesto, N.; Fernández, S.; Ferrero, M.; Gotor, V. Tetrahedron 2006, 62, 5401-5410.  
24. Tian, Z.; Sun, P.; Yan, Y.; Wu, Z.; Zheng,Q.; Zhou, S.; Zhang, H.; Yu, F.; Jia, X. ; 
Chen, D. ; Mándi, A.;; Kurtán, T.; Liu, W. Nat. Chem. Biol. 2015, 11, 259-265. 
25. Grimme, S. J. Comput. Chem. 2006, 27, 1787-1799. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
23 
 
26. Sun,P.; Xu, D.,X.; Mándi, A.; Kurtán,T.; Li, T., J.; Schulz, B.; Zhang, W. J. Org. 
Chem. 2013, 78, 7030-7047. 
27. Wang, D.H.; Cheng, S.Z.; Harris, F.W. Polymer 2008, 49, 3020-3028. 
28. Teichert, A.; Schmidt, J. r.; Porzel, A.; Arnold, N.; Wessjohann, L. J. Nat. Prod. 
2008,71, 1092-1094.  
29. Abraham, W.-R.; G. Spassov, Phytochemistry 1991, 30, 371-372. 
30. Meschke, H., Walter, S.; Schrempf, H. Environ. Microbiol. 2012, 14, 940-952. 
31. Bok, J. W.; Chiang, Y.-M.; Szewczyk, E.; Reyes-Dominguez, Y.; Davidson, A. D.; 
Sanchez, J. F.; Lo, H.C.; Watanabe, K.; Strauss, J.; Oakley, B.R.; Wang, C.C.; Keller, 
N. F. Nat. Chem. Biol. 2009, 5, 462-464. 
32. Kjer, J.; Debbab, A.; Aly, A. H.; Proksch, P. Nat. Protoc. 2010, 5, 479-490.  
33. Anagnostopoulos, C.; Spizizen, J. J. Bacteriol. 1961, 81, 741. 
34. Hopwood, D. A.; Kieser, T.; Wright, H. M.; Bibb, M. J. Microbiology 1983, 129, 
2257-2269. 
35. Cirillo, J. D.; Barletta, R. G.; Bloom, B.; Jacobs, W. J. Bacteriol. 1991, 173, 7772-
7780. 
36. MacroModel; Schrödinger, LLC, 2012, http://www.schrodinger.com/MacroModel. 
37. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; 
Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; 
Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; 
Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; 
Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; 
Montgomery, J. A., Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, 
E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; 
Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. 
M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; 
Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; 
Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; 
Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, O.; Foresman, J. 
B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, revision B.01; Gaussian, Inc.: 
Wallingford, CT 2010. 
38. Stephens, P. J.; Harada, N.. Chirality 2010, 22, 229-233. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
24 
 
39. Varetto, U. MOLEKEL, v. 5.4; Swiss National Supercomputing Centre: Manno,     
Switzerland 2009. 
40.  CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow 
Aerobically; Approved Standard  Ninth ed.; CLSI document M07-A9; Clinical and 
Laboratory Standards Institute: Wayne, PA 2012. 
41.  Ashour, M.;  Edrada R.; Ebel, R.; Wray V.; Wätjen, W.; Padmakumar, K.; Müller, 
W.E.G.; Lin, W. H., Proksch, P. J. Nat. Prod. 2006, 69, 1547-1553. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
25 
 
Figure Legends 
Figure 1. Structures of compounds 1-12. 
 
Figure 2. HPLC chromatograms of EtOAc extracts from co-culture experiments (detection at 
UV 235 nm): (a) B. subtilis control, (b) Chaetomium sp. control, (c) co-culture of 
Chaetomium sp. with autoclaved B. subtilis, (d) co-culture of Chaetomium sp. with viable B. 
subtilis. 
 
Figure 3. Structures and populations of the low-energy B97D/TZVP PCM/MeCN conformers 
(≥2%) of (3R,4R)-8. 
 
Figure 4. Experimental ECD spectrum of 8 in MeCN compared with the Boltzmann-weighted 
B3LYP/TZVP PCM/MeCN ECD spectrum of (3R,4R)-8 computed for the B97D/TZVP 
PCM/MeCN conformers. Bars represent the rotational strength of the lowest-energy 
conformer. 
 
Figure 5. COSY (bold), key ROESY (dashed), and HMBC (plain) correlations of 11 and 12. 
 
